CUI; Yumin
Patent Applications and Registrations
Patent applications and USPTO patent grants for CUI; Yumin.The latest application filed is for "bispecific antigen binding proteins and uses thereof".
- CUI; Yumin - Shanghai CN
| Patent | Date |
|---|---|
| Bispecific Antigen Binding Proteins And Uses Thereof App 20210301018 - HUANG; Zhihua ; et al. | 2021-09-30 |
| Multispecific fab fusion proteins and use thereof Grant 10,870,701 - Cui , et al. December 22, 2 | 2020-12-22 |
| Multispecific Fab Fusion Proteins And Use Thereof App 20190092862 - CUI; Yumin ; et al. | 2019-03-28 |
| Quinazoline compounds Grant 9,168,253 - Zhang , et al. October 27, 2 | 2015-10-27 |
| Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use Grant 8,946,249 - Su , et al. February 3, 2 | 2015-02-03 |
| Pyrimidine derivatives Grant 8,901,143 - Su , et al. December 2, 2 | 2014-12-02 |
| Compound, Certain Novel Forms Thereof, Pharmaceutical Compositions Thereof And Methods For Preparation And Use App 20140200232 - SU; WEI-GUO ; et al. | 2014-07-17 |
| Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use Grant 8,658,658 - Su , et al. February 25, 2 | 2014-02-25 |
| Quinazoline Derivatives App 20130217661 - ZHANG; Weihan ; et al. | 2013-08-22 |
| Use of substituted quinazoline compounds in treating age-related macular degeneration Grant 8,497,372 - Su , et al. July 30, 2 | 2013-07-30 |
| Quinazoline Compounds App 20130172373 - Zhang; Weihan ; et al. | 2013-07-04 |
| Quinazoline derivatives Grant 8,426,430 - Zhang , et al. April 23, 2 | 2013-04-23 |
| Pyrimidine Derivatives App 20130065890 - Su; Wei-Guo ; et al. | 2013-03-14 |
| Pyrimidine derivatives Grant 8,349,859 - Su , et al. January 8, 2 | 2013-01-08 |
| Compound, Certain Novel Forms Thereof, Pharmaceutical Compositions Thereof And Methods For Preparation And Use App 20120270889 - Su; Wei-Guo ; et al. | 2012-10-25 |
| Use Of Substituted Quinazoline Compounds In Treating Angiogenesis-related Diseases App 20120238572 - Su; Wei-Guo ; et al. | 2012-09-20 |
| Use of substituted quinazoline compounds in treating angiogenesis-related diseases Grant 8,212,033 - Su , et al. July 3, 2 | 2012-07-03 |
| Quinazoline Derivatives App 20110015213 - Su; Wei-Guo ; et al. | 2011-01-20 |
| Substituted quinazoline compounds and their use in treating angiogenesis-related diseases Grant 7,829,574 - Su , et al. November 9, 2 | 2010-11-09 |
| Quinazoline Derivatives App 20100009958 - Zhang; Weihan ; et al. | 2010-01-14 |
| Quinazoline Derivatives App 20090281130 - Su; Wei-Guo ; et al. | 2009-11-12 |
| Pyrimidine Derivatives App 20080255172 - Su; Wei-Guo ; et al. | 2008-10-16 |
| Dihydrobenzoquinone Compounds App 20070286906 - Zhang; Weihan ; et al. | 2007-12-13 |
| Anti-cancer agents App 20060160895 - Huang; Weihui ; et al. | 2006-07-20 |
| Cancer chemotherapy App 20060110467 - Huang; Weihui ; et al. | 2006-05-25 |
| Cancer chemotherapy App 20050288378 - Yan, Xiaoqiang ; et al. | 2005-12-29 |
| Benzoquinone compounds as anti-cancer agents App 20050288379 - Yan, Xiaoqiang ; et al. | 2005-12-29 |
| Extract of sophora flavescens flavonoids and uses thereof App 20050226943 - Yan, Xiaoqiang ; et al. | 2005-10-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 